ALTERNATING WEEKLY TEMOZOLOMIDE AS INITIAL TREATMENT FOR PROGRESSIVE LOW-GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY

被引：0
|
作者：
Soffietti, Riccardo [1 ]
Roda, Roberta [1 ]
Trevisan, Elisa [1 ]
Laguzzi, Elena [1 ]
Picco, Elisabetta [1 ]
Guarneri, Dainele [1 ]
Caroli, Manuela [2 ]
Crippa, Flavio [3 ]
机构：
[1] Univ Turin, Turin, Italy
[2] Univ Milan, Milan, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：838 / 838
页数：1
相关论文
共 50 条
  • [31] Temozolomide (TMZ) for 21/28 days in patients with progressive glioblastoma (GBM): Preliminary results of phase II study of gicno (Italian neuro-oncology group)
    Tosoni, A.
    Cavallo, G.
    Scopece, L.
    Franceschi, E.
    Nicolardi, L.
    Roma, A.
    Blatt, V.
    Gioia, V.
    Crino, L.
    Brandes, A. A.
    ANNALS OF ONCOLOGY, 2005, 16 : 63 - 63
  • [32] Phase II study of oral temozolomide (TMZ) in children with progressive low-grade gliomas (LGG)
    Gururangan, S
    Allen, JC
    Phillips, PC
    Dillard, E
    Friedman, HS
    NEURO-ONCOLOGY, 2004, 6 (04) : 457 - 457
  • [33] Final results of depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO)
    Padovan, M.
    Eoli, M.
    Pellerino, A.
    Rizzato, S.
    Caserta, C.
    Simonelli, M.
    Michiara, M.
    Caccese, M.
    Anghileri, E.
    Finocchiaro, G.
    Zagonel, V.
    Ruda, R.
    Lombardi, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S399 - S400
  • [34] Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
    Padovan, Marta
    Eoli, Marica
    Pellerino, Alessia
    Rizzato, Simona
    Caserta, Claudia
    Simonelli, Matteo
    Michiara, Maria
    Caccese, Mario
    Anghileri, Elena
    Cerretti, Giulia
    Ruda, Roberta
    Zagonel, Vittorina
    Lombardi, Giuseppe
    CANCERS, 2021, 13 (11)
  • [35] A phase II study of temozolomide in the treatment of adult patients with supratentorial low-grade glioma.
    Wahl, Michael Traut
    Aicardi, Jonathan
    Haas-Kogan, Daphne A.
    Butowski, Nicholas A.
    Clarke, Jennifer Leigh
    Prados, Michael
    Phillips, Joanna J.
    Berger, Mitchel S.
    Chang, Susan Marina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
    Veronica Villani
    Elena Anghileri
    Luca Prosperini
    Giuseppe Lombardi
    Roberta Rudà
    Paola Gaviani
    Simona Rizzato
    Gaetano Lanzetta
    Alessandra Fabi
    Claudia Scaringi
    Edoardo Pronello
    Giorgia Simonetti
    Giada Targato
    Andrea Pace
    Journal of Neurology, 2021, 268 : 2866 - 2875
  • [37] Depatuxizumab mafodotin (Depatux-M) plus temozolomide (TMZ) in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO).
    Caccese, Mario
    Padovan, Marta
    Eoli, Marica
    Pellerino, Alessia
    Rizzato, Simona
    Caserta, Claudia
    Simonelli, Matteo
    Michiara, Maria
    Zagonel, Vittorina
    Ruda, Roberta
    Lombardi, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
    Villani, Veronica
    Anghileri, Elena
    Prosperini, Luca
    Lombardi, Giuseppe
    Ruda, Roberta
    Gaviani, Paola
    Rizzato, Simona
    Lanzetta, Gaetano
    Fabi, Alessandra
    Scaringi, Claudia
    Pronello, Edoardo
    Simonetti, Giorgia
    Targato, Giada
    Pace, Andrea
    JOURNAL OF NEUROLOGY, 2021, 268 (08) : 2866 - 2875
  • [39] Temozolomide (TMZ) for 21/28 days in patients with progressive glioblastoma (GBM):: Preliminary results of phase 2 study of GICNO (Italian Neuro-Oncology Group)
    Brandes, A
    Cavallo, G
    Tosoni, A
    Ermani, M
    Scopece, L
    Franceschi, E
    Nicolardi, L
    Talacchi, A
    Blatt, V
    Crinò, L
    NEURO-ONCOLOGY, 2005, 7 (03) : 312 - 312
  • [40] Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)
    Lombardi, Giuseppe
    Pace, Andrea
    Pasqualetti, Francesco
    Rizzato, Simona
    Faedi, Marina
    Anghileri, Elena
    Nicolotto, Elisa
    Bazzoli, Elena
    Bellu, Luisa
    Villani, Veronica
    Fabi, Alessandra
    Ferrazza, Patrizia
    Gurrieri, Lorena
    Dall'Agata, Monia
    Eoli, Marica
    Della Puppa, Alessandro
    Pambuku, Ardi
    D'Avella, Domenico
    Berti, Franco
    Ruda, Roberta
    Zagonel, Vittorina
    JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (02) : 359 - 367
12345